InBioGen Co Ltd Cash Flow Conversion Efficiency
InBioGen Co Ltd cash flow conversion efficiency. Based on the latest financial reports, InBioGen Co Ltd (101140) has a cash flow conversion efficiency ratio of -0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.67 Billion ≈ $-1.13 Million USD) by net assets (₩170.78 Billion ≈ $115.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of InBioGen Co Ltd (2013–2024)
Cash flow conversion efficiency of InBioGen Co Ltd from 2013 to 2024. This chart illustrates how InBioGen Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest InBioGen Co Ltd stock price today for real-time trading data and today's change.
InBioGen Co Ltd Cash Flow Conversion Ratio Explained
InBioGen Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
InBioGen Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of InBioGen Co Ltd ranked by their cash flow conversion efficiency. Also see 101140 market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ANAX Metals Ltd
AU:ANX
|
-0.076x |
|
NATUZZI S.P.A. ADR/5 EO 1
F:NTZA
|
-0.043x |
|
Asia Brands Bhd
KLSE:7722
|
0.015x |
|
Sound Group Inc.
NASDAQ:SOGP
|
N/A |
|
Rossmax International Ltd
TWO:4121
|
0.044x |
|
Quonia SOCIMI SA
MC:YQUO
|
0.013x |
|
Vivid Seats Inc
NASDAQ:SEAT
|
0.008x |
|
Grid Metals Corp
V:GRDM
|
-165.526x |
Annual Cash Flow Conversion Efficiency for InBioGen Co Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of InBioGen Co Ltd from 2013 to 2024. Review InBioGen Co Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩159.84 Billion ≈ $108.32 Million |
₩-33.13 Million ≈ $-22.45K |
0.000x | +97.07% |
| 2023-12-31 | ₩148.68 Billion ≈ $100.76 Million |
₩-1.05 Billion ≈ $-712.04K |
-0.007x | +93.59% |
| 2022-12-31 | ₩104.42 Billion ≈ $70.76 Million |
₩-11.51 Billion ≈ $-7.80 Million |
-0.110x | -177.48% |
| 2021-12-31 | ₩178.02 Billion ≈ $120.64 Million |
₩-7.07 Billion ≈ $-4.79 Million |
-0.040x | +61.49% |
| 2020-12-31 | ₩77.91 Billion ≈ $52.80 Million |
₩-8.03 Billion ≈ $-5.44 Million |
-0.103x | -77.77% |
| 2019-12-31 | ₩66.00 Billion ≈ $44.72 Million |
₩-3.83 Billion ≈ $-2.59 Million |
-0.058x | +20.27% |
| 2018-12-31 | ₩23.35 Billion ≈ $15.83 Million |
₩-1.70 Billion ≈ $-1.15 Million |
-0.073x | -93.19% |
| 2017-12-31 | ₩11.32 Billion ≈ $7.67 Million |
₩-426.44 Million ≈ $-288.99K |
-0.038x | -162.82% |
| 2016-12-31 | ₩5.75 Billion ≈ $3.90 Million |
₩344.75 Million ≈ $233.63K |
0.060x | +104.27% |
| 2015-12-31 | ₩7.80 Billion ≈ $5.29 Million |
₩-10.96 Billion ≈ $-7.43 Million |
-1.405x | -732.60% |
| 2014-12-31 | ₩4.12 Billion ≈ $2.79 Million |
₩-695.95 Million ≈ $-471.63K |
-0.169x | +45.32% |
| 2013-12-31 | ₩3.67 Billion ≈ $2.49 Million |
₩-1.13 Billion ≈ $-767.47K |
-0.309x | -- |
About InBioGen Co Ltd
INBIOGEN Co., Ltd. engages in the manufacture and distribution of footwear products in South Korea. It is also involved in distribution of wood pellets; kiosk; and food and beverage businesses. The company was formerly known as BTONE CO.,Ltd. INBIOGEN Co., Ltd. was founded in 1949 and is headquartered in Seoul, South Korea.